Notably, reducing NRF2 expression decreased the viability of NSCLC cells and substantially raised the levels of MDA, a byproduct of lipid peroxidation (Fig. 6, J and K), which indicts the ferroptosis tolerance capability decrease. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.